Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Dow
McKinsey
Merck
Baxter

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Forest Laboratories Inc. v. Apotex Corp. (D. Del. 2014)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Forest Laboratories Inc. v. Apotex Corp. (D. Del. 2014)

Docket   Start Trial Date Filed 2014-02-14
Court District Court, D. Delaware Date Terminated 2016-02-16
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties ACTAVIS LABORATORIES FL INC.; ADAMAS PHARMACEUTICALS INC.; ANCHEN PHARMACEUTICALS INC.; APOTEX CORP.; APOTEX INC.; CADILA HEALTHCARE LTD.; FOREST LABORATORIES HOLDINGS LTD.; FOREST LABORATORIES INC.; PAR PHARMACEUTICAL INC.; WATSON LABORATORIES INC. - FLORIDA; ZYDUS PHARMACEUTICALS (USA) INC.
Patents 8,168,209; 8,173,708; 8,283,379; 8,329,752; 8,362,085; 8,598,233
Attorneys Damien Nicholas Tancredi; Dominick T. Gattuso; Francis J. Murphy , Jr.; Jack B. Blumenfeld; John K. Hsu; John W. Shaw; Joseph James Bellew; Maryellen Noreika; Sharick Naqi
Link to Docket External link to docket
Small Molecule Drugs cited in Forest Laboratories Inc. v. Apotex Corp.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Forest Laboratories Inc. v. Apotex Corp. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-02-14 1 quot;the '708 patent"); 8,283,379 ("the '379 patent"); 8,329,752 ("the '…#39;009 patent, the '209 patent, the '708 patent, the '379 patent, the '752 patent, the … '009 patent, the '209 patent, the '708 patent, the ‘379 patent, the ‘752 patent, and the …#39;009 patent, the '209 patent. the '708 patent, the ‘3 79 patent, the '752 patent, the '…#39;009 patent, the '209 patent, the '708 patent, the '379 patent, the '752 patent, the External link to document
2016-02-11 217 infringement of U.S. Patent Nos. 8,039,009 (“the ‘009 Patent”); 8,168,209 (“the ‘209 Patent”); 8,173,708 (“…‘009 Patent, the ‘209 Patent, the ‘708 Patent, the ‘379 Patent, the ‘752 Patent, the ‘085 Patent, and…‘009 Patent, the ‘209 Patent, the ‘708 Patent, the ‘379 Patent, the ‘752 Patent, the ‘085 Patent, and…‘009 Patent, the ‘209 Patent, the ‘708 Patent, the ‘379 Patent, the ‘752 Patent, the ‘085 Patent, the…‘009 Patent, the ‘209 Patent, the ‘708 Patent, the ‘379 Patent, the ‘752 Patent, the ‘085 Patent, and External link to document
2014-02-14 3 Expiration of Patent: 8,039,009-03/24/2029; 8,168,209, 8,173,708, 8,283,379, 8,329,752, 8,362,085, 8,… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 16 February 2016 1:14-cv-00200 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
AstraZeneca
Medtronic
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.